Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury

被引:158
作者
Siegel, Matthew [1 ]
Strnad, Pavel [2 ]
Watts, R. Edward [3 ]
Choi, Kihang [3 ]
Jabri, Bana [4 ]
Omary, M. Bishr [2 ]
Khosla, Chaitan [1 ,3 ,5 ]
机构
[1] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA
[2] VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA
[3] Stanford Univ, Dept Chem, Stanford, CA USA
[4] Univ Chicago, Dept Pathol, Med & Pediat, Chicago, IL USA
[5] Stanford Univ, Dept Biochem, Stanford, CA USA
来源
PLOS ONE | 2008年 / 3卷 / 03期
关键词
D O I
10.1371/journal.pone.0001861
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transglutaminase 2 (TG2) is a multifunctional mammalian protein with transamidase and signaling properties. Using selective TG2 inhibitors and tagged nucleophilic amine substrates, we show that the majority of extracellular TG2 is inactive under normal physiological conditions in cell culture and in vivo. However, abundant TG2 activity was detected around the wound in a standard cultured fibroblast scratch assay. To demonstrate wounding-induced activation of TG2 in vivo, the toll-like receptor 3 ligand, polyinosinic-polycytidylic acid (poly(I:C)), was injected in mice to trigger small intestinal injury. Although no TG2 activity was detected in vehicle-treated mice, acute poly(I:C) injury resulted in rapid TG2 activation in the small intestinal mucosa. Our findings provide a new basis for understanding the role of TG2 in physiology and disease.
引用
收藏
页数:11
相关论文
共 47 条
  • [1] AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
  • [2] Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin
    Akimov, SS
    Krylov, D
    Fleischman, LF
    Belkin, AM
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (04) : 825 - 838
  • [3] Akimov SS, 2001, J CELL SCI, V114, P2989
  • [4] Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells
    Antonyak, MA
    Miller, AM
    Jansen, JM
    Boehm, JE
    Balkman, CE
    Wakshlag, JJ
    Page, RL
    Cerione, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41461 - 41467
  • [5] Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity
    Begg, GE
    Holman, SR
    Stokes, PH
    Matthews, JM
    Graham, RM
    Iismaa, SE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (18) : 12603 - 12609
  • [6] Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient
    Bernassola, F
    Federici, M
    Corazzari, M
    Terrinoni, A
    Hribal, ML
    De Laurenzi, V
    Ranalli, M
    Massa, O
    Sesti, G
    Mclean, WHI
    Citro, G
    Barbetti, F
    Melino, G
    [J]. FASEB JOURNAL, 2002, 16 (11) : 1371 - 1378
  • [7] Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates
    Case, A
    Stein, RL
    [J]. BIOCHEMISTRY, 2003, 42 (31) : 9466 - 9481
  • [8] Chemistry and biology of dihydroisoxazole derivatives: Selective inhibitors of human transglutaminase 2
    Choi, K
    Siegel, M
    Piper, JL
    Yuan, L
    Cho, E
    Strnad, P
    Omary, B
    Rich, KM
    Khosla, C
    [J]. CHEMISTRY & BIOLOGY, 2005, 12 (04): : 469 - 475
  • [9] HUMAN-SERUM TRANSGLUTAMINASE AND CELIAC-DISEASE - CORRELATION BETWEEN SERUM AND MUCOSAL ACTIVITY IN AN EXPERIMENTAL-MODEL OF RAT SMALL BOWEL ENTEROPATHY
    DARGENIO, G
    SORRENTINI, I
    CIACCI, C
    SPAGNUOLO, S
    VENTRIGLIA, R
    DECHIARA, A
    MAZZACCA, G
    [J]. GUT, 1989, 30 (07) : 950 - 954
  • [10] Gene disruption of tissue transglutaminase
    De Laurenzi, V
    Melino, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (01) : 148 - 155